D
Emergent BioSolutions Inc. EBS
$5.71 $0.203.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -31.30M 114.80M -283.10M 9.00M -49.50M
Total Depreciation and Amortization 26.00M 26.40M 28.50M 27.90M 29.60M
Total Amortization of Deferred Charges 2.20M -6.70M 5.00M 6.90M 5.70M
Total Other Non-Cash Items 8.50M -46.40M 91.20M -8.90M 3.50M
Change in Net Operating Assets -85.30M 65.60M 205.90M -97.50M 42.80M
Cash from Operations -79.90M 153.70M 47.50M -62.60M 32.10M
Capital Expenditure -1.70M -5.80M -4.60M -10.80M -11.40M
Sale of Property, Plant, and Equipment 300.00K 7.60M -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures 0.00 110.20M -- -- 0.00
Other Investing Activities 30.00M -- -- -- 0.00
Cash from Investing 28.60M 112.00M -4.60M -10.80M -11.40M
Total Debt Issued 0.00 219.00M 15.00M 50.00M 20.00M
Total Debt Repaid 0.00 -413.00M -60.50M -8.90M -15.90M
Issuance of Common Stock 800.00K 9.30M 700.00K -- 700.00K
Repurchase of Common Stock -300.00K -300.00K -200.00K -400.00K -100.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 4.70M -5.90M -- --
Cash from Financing 500.00K -180.30M -50.90M 40.70M 4.70M
Foreign Exchange rate Adjustments -- -- -- -- -1.50M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -50.80M 85.40M -8.00M -32.70M 23.90M
Weiss Ratings